These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 38278268)

  • 21. Associations of prenatal exposure to perfluoroalkyl substances with preterm birth: A family-based birth cohort study.
    Yu Y; Qin XD; Bloom MS; Chu C; Dai X; Li QQ; Chen ZX; Kong ML; Xie YQ; Meng WJ; Yang BY; Hu LW; Zeng XW; Zhao XM; Zhou Y; Dong GH
    Environ Res; 2022 Nov; 214(Pt 1):113803. PubMed ID: 35810818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic Perturbations Associated with an Exposure Mixture of Per- and Polyfluoroalkyl Substances in the Atlanta African American Maternal-Child Cohort.
    Liang D; Taibl KR; Dunlop AL; Barr DB; Ryan PB; Everson T; Huels A; Tan Y; Panuwet P; Kannan K; Marsit C; Jones DP; Eick SM
    Environ Sci Technol; 2023 Oct; 57(43):16206-16218. PubMed ID: 37857362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse birth outcomes related to concentrations of per- and polyfluoroalkyl substances (PFAS) in maternal blood collected from pregnant women in 1960-1966.
    Zheng T; Kelsey K; Zhu C; Pennell KD; Yao Q; Manz KE; Zheng YF; Braun JM; Liu Y; Papandonatos G; Liu Q; Shi K; Brochman S; Buka SL
    Environ Res; 2024 Jan; 241():117010. PubMed ID: 37696323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First trimester plasma PER- AND Polyfluoroalkyl Substances (PFAS) and blood pressure trajectories across the second and third trimesters of pregnancy.
    Burdeau JA; Stephenson BJK; Aris IM; Preston EV; Hivert MF; Oken E; Mahalingaiah S; Chavarro JE; Calafat AM; Rifas-Shiman SL; Zota AR; James-Todd T
    Environ Int; 2024 Apr; 186():108628. PubMed ID: 38583297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of Prenatal Per- and Polyfluoroalkyl Substance (PFAS) Exposures with Offspring Adiposity and Body Composition at 16-20 Years of Age: Project Viva.
    Zhang M; Rifas-Shiman SL; Aris IM; Fleisch AF; Lin PD; Nichols AR; Oken E; Hivert MF
    Environ Health Perspect; 2023 Dec; 131(12):127002. PubMed ID: 38054701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of diet with per- and polyfluoroalkyl substances in plasma and human milk in the New Hampshire Birth Cohort Study.
    Wang Y; Gui J; Howe CG; Emond JA; Criswell RL; Gallagher LG; Huset CA; Peterson LA; Botelho JC; Calafat AM; Christensen B; Karagas MR; Romano ME
    Sci Total Environ; 2024 Jul; 933():173157. PubMed ID: 38740209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
    Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
    Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between prenatal exposure to per- and polyfluoroalkyl substances and infant anthropometry: A prospective cohort study.
    Li J; Su X; Zhou Y; Ji H; Xie Z; Sun S; Wang Z; Yuan W; Miao M; Liang H
    Int J Hyg Environ Health; 2024 Apr; 257():114339. PubMed ID: 38401404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of single and multiple prefluoroalkyl substances exposure with preterm birth: Results from a Chinese birth cohort study.
    Liao Q; Tang P; Song Y; Liu B; Huang H; Liang J; Lin M; Shao Y; Liu S; Pan D; Huang D; Qiu X
    Chemosphere; 2022 Nov; 307(Pt 1):135741. PubMed ID: 35863418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual and joint associations of per- and polyfluoroalkyl substances (PFAS) with gallstone disease in adults: A cross-sectional study.
    Shi T; Li D; Li D; Sun J; Xie P; Wang T; Li R; Li Z; Zou Z; Ren X
    Chemosphere; 2024 Jun; 358():142168. PubMed ID: 38685323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal per- and polyfluoroalkyl substances (PFAS) exposure in relation to preterm birth subtypes and size-for-gestational age in the LIFECODES cohort 2006-2008.
    Siwakoti RC; Cathey A; Ferguson KK; Hao W; Cantonwine DE; Mukherjee B; McElrath TF; Meeker JD
    Environ Res; 2023 Nov; 237(Pt 2):116967. PubMed ID: 37634691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between serum per- and polyfluoroalkyl substances as mixtures and lipid levels: A cross-sectional study in Jinan.
    Liu Y; Zhang H; Xu F; Zhang X; Zhao N; Ding L
    Sci Total Environ; 2024 May; 923():171305. PubMed ID: 38423340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between perfluoroalkyl and polyfluoroalkyl substances exposure and fetal overgrowth: A prospective birth cohort study conducted in China.
    Pan D; Song Y; Liu S; Zeng X; Pang Q; Zhang Y; Wu H; Tan HJJ; Liao Q; Liang J; Huang D; Qiu X
    Environ Res; 2023 Sep; 232():116175. PubMed ID: 37257750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Per- and polyfluoroalkyl substances in umbilical cord serum and body mass index trajectories from birth to age 10 years: Findings from a longitudinal birth cohort (SMBCS).
    Dai Y; Zhang J; Wang Z; Ding J; Xu S; Zhang B; Guo J; Qi X; Chang X; Wu C; Zhou Z
    Environ Int; 2023 Oct; 180():108238. PubMed ID: 37783122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between serum perfluoroalkyl and polyfluoroalkyl concentrations and diabetes mellitus in the Korean general population: Insights from the Korean National Environmental Health Survey 2018-2020.
    Kang H; Kim SH
    Int J Hyg Environ Health; 2024 Jun; 259():114385. PubMed ID: 38676994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
    Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
    Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: The HOME Study.
    Lebeaux RM; Doherty BT; Gallagher LG; Zoeller RT; Hoofnagle AN; Calafat AM; Karagas MR; Yolton K; Chen A; Lanphear BP; Braun JM; Romano ME
    Environ Res; 2020 Jun; 185():109395. PubMed ID: 32222633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.